- Home
- NCMI vs LAB Comparison
NCMI vs LAB Comparison
Compare NCMI & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCMI
- LAB
- Stock Information
- Founded
- NCMI 2005
- LAB 1999
- Country
- NCMI United States
- LAB United States
- Employees
- NCMI N/A
- LAB N/A
- Industry
- NCMI Advertising
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- NCMI Consumer Discretionary
- LAB Industrials
- Exchange
- NCMI Nasdaq
- LAB Nasdaq
- Market Cap
- NCMI 666.3M
- LAB 562.1M
- IPO Year
- NCMI 2007
- LAB 2011
- Fundamental
- Price
- NCMI $6.69
- LAB $1.30
- Analyst Decision
- NCMI Strong Buy
- LAB Strong Buy
- Analyst Count
- NCMI 4
- LAB 2
- Target Price
- NCMI $7.56
- LAB $2.88
- AVG Volume (30 Days)
- NCMI 384.1K
- LAB 1.8M
- Earning Date
- NCMI 03-17-2025
- LAB 02-26-2025
- Dividend Yield
- NCMI N/A
- LAB N/A
- EPS Growth
- NCMI N/A
- LAB N/A
- EPS
- NCMI N/A
- LAB N/A
- Revenue
- NCMI $245,300,000.00
- LAB $155,902,000.00
- Revenue This Year
- NCMI $47.09
- LAB $62.60
- Revenue Next Year
- NCMI $19.46
- LAB $9.19
- P/E Ratio
- NCMI N/A
- LAB N/A
- Revenue Growth
- NCMI 47.68
- LAB 48.23
- 52 Week Low
- NCMI $3.71
- LAB $1.17
- 52 Week High
- NCMI $7.60
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- NCMI 44.24
- LAB 35.51
- Support Level
- NCMI $6.90
- LAB $1.17
- Resistance Level
- NCMI $7.25
- LAB $1.51
- Average True Range (ATR)
- NCMI 0.23
- LAB 0.10
- MACD
- NCMI -0.03
- LAB 0.00
- Stochastic Oscillator
- NCMI 34.88
- LAB 32.50
About NCMI National CineMedia Inc.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.